1 asset in Neuromuscular Junction Disease
Therapeutic assets addressing Neuromuscular Junction Disease, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Rocuronium Ion Neuromuscular Junction Disease | Merck Sharp & Dohme LLC | P4 | BB (69) |